Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | 171.89 | 132.04 | 134.51 | 124.33 | 52.73 |
| Net cashflow-operating activity | 34.05 | 51.73 | 50.97 | 107.07 | 118.01 |
| Net cash used in investing activity | -114.22 | -194.62 | -8.40 | 8.82 | -24.10 |
| Netcash used in fin. activity | -26.22 | 210.02 | 75.86 | -13.53 | -92.29 |
| Net inc/dec in cash and equivlnt | -106.38 | 67.12 | 118.44 | 102.36 | 1.63 |
| Cash and equivalnt begin of year | 148.31 | 81.19 | 105.61 | 3.35 | 1.12 |
| Cash and equivalnt end of year | 41.93 | 148.31 | 224.05 | 105.71 | 2.75 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis